Dr. Jingfang Mao 茅静芳
Chief Physician
Thoracic Surgery, Shanghai Proton and Heavy Ion Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiation therapy and comprehensive care for chest tumors, including lung cancer, esophageal cancer, mediastinal tumors such as thymoma, and tracheal tumors like adenoid cystic carcinoma. Specializes in proton and heavy ion radiotherapy.
Dr. Mao earned an MD from Fudan University Shanghai Medical College in 2000 and a PhD in radiation oncology in 2007. After working at Fudan University Shanghai Cancer Center since 2000, Dr. Mao joined Shanghai Proton and Heavy Ion Center. Training includes visits to Duke University (2004–2006), Heidelberg Ion Beam Therapy Center (2013), and National Institute of Radiological Sciences, Japan (2014).
Name order: in Chinese the family name comes first (Mao Jingfang). Papers usually list the name as Jingfang Mao or Mao J.
Selected publications
31 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Radiat Oncol Biol Phys, 2026 (senior author): Comparing Strategies for Pencil Beam Scanning Carbon Ion Radiation Therapy in Stage I Peripheral Non-Small Cell Lung Cancer: Toward Optimized Clinical Decision-Making Planning. PubMed 42595262
- BMC Cancer, 2026 (senior author): Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma. PubMed 42458346
- Radiat Oncol, 2026 (senior author): Normal tissue complication probability modelling and predicting for carbon-ion radiotherapy-induced symptomatic esophageal and tracheobronchial injuries in locally advanced non-small cell lung cancer. PubMed 42316224
- Int J Radiat Oncol Biol Phys, 2025 (senior author): Carbon Ion Radiation Therapy with Pencil Beam Scanning for Stage III Non-Small Cell Lung Cancer: Toxicity Profiles, Survival Outcomes, and Prognostic Indicators. PubMed 39921110
- Radiat Oncol, 2023 (senior author): Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis. PubMed 38041122
- Front Oncol, 2021 (senior author): Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer. PubMed 34858845
- Radiat Oncol, 2019 (senior author): Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy. PubMed 30683133
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion